Investigating whether a new portable self-management system can help people with diabetes manage their blood glucose levels, adhere to treatment plans and improve quality of life.

Actiste is a combined product and service that brings together a blood sampler, blood glucose meter and insulin pen in a connected smart device for daily diabetes care.

The study is being carried out by a team based at the Salford Care Organisation, part of the Northern Care Alliance NHS Foundation Trust, on behalf of Swedish health-tech company, Brighter.


  • Aged 18+
  • Resident in Greater Manchester
  • Diagnosed with type 1 or type 2 diabetes for more than six months
  • Currently using insulin glargine U100 injection, for example Lantus or others
  • Able to download and use a smartphone app


  • Salford Care Organisation (part of Northern Care Alliance)


  • Using the Actiste product and smartphone app for six months
  • Attending several visits during the study period which will include a range of tests (eg blood glucose) as well as questions about lifestyle and treatment satisfaction.

Recruiting until

  • 31 December 2022

Trial ID

  • S21DIAB02-S

Want to take part or learn more?